BARCELONA, Spain and DÜSSELDORF, Germany, July 24, 2026 -- Minoryx Therapeutics and Neuraxpharm Group, announce that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has...
Plexxikon Gets $15M Investment For Diabetes Drug Development (BioWorld Today)
News | 05. 27. 2004
Plexxikon
Plexxikon Inc. raised $15 million in venture financing to complete a Series B extension round.
